D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression

Journal of Hypertension

Volumn 27, Issue 5, 2009, Pages 1033-1041

  Zeng, Chunyu ^a,b   Han, Yu ^a   Huang, Hefei ^a   Yu, Changqing ^a   Ren, Hongmei ^a   Shi, Weibin ^a   He, Duofen ^a   Huang, Lan ^b   Yang, Chengming ^a   Wang, Xukai ^a   Zhou, Lin ^a,b   Jose, Pedro A ^c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine receptor; Insulin; Proliferation; Vascular smooth muscle cells

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; D1 LIKE RECEPTOR; FENOLDOPAM; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE C; THYMIDINE; UNCLASSIFIED DRUG; DOPAMINE 1 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ESSENTIAL HYPERTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR RING; VASCULAR SMOOTH MUSCLE; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT; RAT; RAT STRAIN; THORACIC AORTA; TIME;

ANIMALS; AORTA, THORACIC; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FENOLDOPAM; IMMUNOHISTOCHEMISTRY; INSULIN; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED STRAINS; RECEPTOR, INSULIN; RECEPTORS, DOPAMINE D1; TIME FACTORS;

EID: 67649798578     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283293c7b     Document Type: Article

References (49)

1. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res 2008; 102:401-414.
2. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 2004; 286:H1597-H1602.
3. Nigro J, Osman N, Dart AM, Little PJ. Insulin resistance and atherosclerosis. Endocr Rev 2006; 27:242-259.
4. + exchanger NHE3 by insulin. Am J Physiol Renal Physiol 2007; 292:F577-F585.
5. Song J, Hu X, Riazi S, Tiwari S, Wade JB, Ecelbarger CA. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol Renal Physiol 2006; 290:F1055-F1064.
6. + channel. Pflugers Arch 2005; 451:445-453.
7. White PW, Abularrage CJ, Weiswasser JM, Kellicut DC, Arora S, Sidawy AN. Hypoxia attenuates insulin-induced proliferation and migration of human diabetic infrapopliteal vascular smooth muscle cells. Ann Vasc Surg 2006; 20:381-386.
8. Tuck ML, Bounoua F, Eslami P, Nyby MD, Eggena P, Corry DB. Insulin stimulates endogenous angiotensin II production via a mitogen-activated protein kinase pathway in vascular smooth muscle cells. J Hypertens 2004; 22:1779-1785.
9. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294:H551-H569.
10. Bertorello AM, Sznajder JI. The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks. Am J Respir Cell Mol Biol 2005; 33:432-437.
11. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 2003; 228:134-142.
12. 3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 2004; 43:673-679.
13. Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, Pratt RE. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 1997; 35:158-167.
14. Wolf G, Ziyadeh FN, Stahl RA. Atrial natriuretic peptide stimulates the expression of transforming growth factor-beta in cultured murine mesangial cells: relationship to suppression of proliferation. J Am Soc Nephrol 1995; 6:224-233.
15. Li Z, Zeng C, Han Y, Liu Y, He D, Huang H, etal. Inhibitory effect of D1 and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2008; 294:H2761-2768.
16. Kimes BW, Brandt BL. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 1976; 98:349-366.
17. Johansson GS, Arnqvist HJ. Insulin IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 2006; 291: E1124-E1130.
18. Sachdev D, Singh R, Fujita-Yamaguchi Y, Yee D. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for antiinsulin-like growth factor therapy in breast cancer. Cancer Res 2006; 66:2391-2402.
19. Yu P, Asico LD, Luo Y, Andrews P, Eisner GM, Hopfer U, et al. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int 2006; 70:1072-1079.
20. Sanada H, Asico LD, Shigetomi S, Tanaka K, Niimura S, Watanabe H, et al. The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats. Clin Exp Hypertens 2000; 22:419-429.
21. 1 angiotensin receptor expression in rat renal proximal tubule cells. Circ Res 2006; 99:494-500.
22. Okamoto H, Fujioka Y, Takahashi A, Takahashi T, Taniguchi T, Ishikawa Y, Yokoyama M. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21 (WAF1). J Atheroscler Thromb 2006; 13:183-191.
23. Parmentier JH, Smelcer P, Pavicevic Z, Basic E, Idrizovic A, Estes A, Malik KU. PKC-zeta mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertension 2003; 41:794-800.
24. 1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats. Am J Physiol Renal Physiol 2006; 290:F1024-F1033.
25. Muthusamy T, Dhevika S, Murugesan P, Balasubramanian K. Testosterone deficiency impairs glucose oxidation through defective insulin and its receptor gene expression in target tissues of adult male rats. Life Sci 2007; 81:534-542.
26. Xapelli S, Bernardino L, Ferreira R, Grade S, Silva AP, Salgado JR, et al. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia. Eur J Neurosci 2008; 27:2089-2102.
27. Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, et al. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 2006; 70:676-685.
28. Bobalova J, Mutafova-Yambolieva VN. Activation of the adenylyl cyclase/protein kinase A pathway facilitates neural release of b-nicotinamide adenine dinucleotide in canine mesenteric artery. Eur J Pharmacol 2006; 536:128-132.
29. Curran MP, Robinson DM, Keating GM. Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs 2006; 66:1755-1782.
30. Michlig S, Mercier A, Doucet A, Schild L, Horisberger JD, Rossier BC, Firsov D. ERK1/2 controls Na, K-ATPase activity and transepithelial sodium transport in the principal cell of the cortical collecting duct of the mouse kidney. J Biol Chem 2004; 279:51002-51012.
31. Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH. T3 increases Na-K-ATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294:L749-L754.
32. 2= channels in marginal cells in the stria vascularis of guinea pigs. J Physiol Sci 2007; 57:287-298.
33. 2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 2005; 280:36824-36832.
34. 2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab 2006; 291:E1038-F1043.
35. Segers O, Anckaert E, Gerlo E, Dupont AG, Somers G. Dopamine-sodium relationship in type 2 diabetic patients. Diabetes Res Clin Pract 1996; 34:89-98.
36. Shigetomi S, Yamada ZO, Ishii H, Sanada H, Watanabe H, Fukuchi S. Dopaminergic activity and endorenal dopamine synthesis in noninsulin dependent diabetes mellitus. Hypertens Res 1995; 18:S125-S130.
37. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S. Mechanism of sodium load-induced hypertension in noninsulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res 2001; 24:127-135.
38. Banday AA, Asghar M, Hussain T, Lokhandwala MF. Dopamine-mediated inhibition of renal Na, K-ATPase is reduced by insulin. Hypertension 2003; 41:1353-1358.
39. Umrani DN, Goyal RK. Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. Clin Exp Hypertens 2003; 25:221-233.
40. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19:233-246.
41. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 1998; 32:187-197.
42. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62:621-647.
43. Felder CC, Blecher M, Jose PA. Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. J Biol Chem 1989; 264:8739-8745.
44. 2+ signaling in striatal medium spiny neurons. J Biol Chem 2004; 279:42082-42094.
45. Yao LP, Li XX, Yu PY, Xu J, Asico LD, Jose PA. Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 1998; 32:1049-1053.
46. Pedemonte CH, Efendiev R, Bertorello AM. Inhibition of Na, K-ATPase by dopamine in proximal tubule epithelial cells. Semin Nephrol 2005; 25:322-327.
47. Asghar M, Kansra V, Hussain T, Lokhandwala MF. Hyperphosphorylation of Na-pump contributes to defective renal dopamine response in old rats. J Am Soc Nephrol 2001; 12:226-232.
48. Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, et al. Inhibition of protein kinase C epsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 2007; 117:739-745.
49. 1-like receptors. Arterioscler Thromb Vasc Biol 1997; 17:3164-3173.